Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGND) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

2.4 / 5 stars · 57/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 149.84 thousand shares as of 2012-06-30, per its 10-Q/A filed 2012-11-14.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2012-11-14

  • 2012-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 149.84K shares.
  • 2011-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 115.51K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
2012-06-30149.84K shares
10-Q/A · filed 2012-11-14
2011-12-31115.51K shares
10-Q/A · filed 2012-11-14